Clinical significance of BRAF mutations in metastatic melanoma

Forty to eighty percent of melanoma tumors have activating mutations in BRAF although the clinical importance of these mutations is not clear. We previously reported an analysis of BRAF mutations in metastatic melanoma samples from 68 patients. In this study, we correlated patient baseline character...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, David Z, Panageas, Katherine S, Osman, Iman, Polsky, David, Busam, Klaus, Chapman, Paul B
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544849/
https://www.ncbi.nlm.nih.gov/pubmed/15613230
http://dx.doi.org/10.1186/1479-5876-2-46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544849/
https://www.ncbi.nlm.nih.gov/pubmed/15613230
http://dx.doi.org/10.1186/1479-5876-2-46

Ejemplares similares